People
Elisabeth Kohoutek advises companies in the Life Sciences sectors. Elisabeth guides clients in complex regulatory matters and represents them in litigation and business transactions.
Elisabeth is passionate about Digital Health and an expert on privacy, AI, and health laws.
As a member of our FDA & Life Sciences practice, Elisabeth counsels companies in the drug, device, food, cosmetics, chemical and related industries. Elisabeth focuses on advertising, labeling, classification, composition, regulatory compliance, ESG and privacy matters under both European Union (EU) and German laws. With more than 10 years of practice, Elisabeth has broad experience in solving issues in highly regulated sectors, both out-of-court and in court proceedings and transactions.
Determined to bring forward the health system and to improve patient treatment options, Elisabeth is an active part of the Digital Health movement.
Legal 500 Deutschland ranks Elisabeth Kohoutek among Germany's leading lawyers for Healthcare and Life Sciences. LMG Life Sciences EMEA 2022 shortlisted her as "Non-IP Litigation Rising Star". Expert Guides Rising Stars named Elisabeth Kohoutek a "Rising Star" for Life Sciences in its 2022 edition.
Elisabeth studied law at the Ruprecht-Karls-University in Heidelberg.
She speaks German, English, Czech and Spanish.
State Exam, Ruprecht-Karls-Universität Heidelberg
Frankfurt
Frankfurt, Germany (Admitted 3/8/2012; Reg. # 148821)
Czech
English
German
Spanish
April 12, 2023
Legal 500 EMEA 2023 Recognizes King & Spalding among the Top Firms in Europe, the Middle East and Africa
February 17, 2023
Legal 500 Deutschland 2023 Recognizes King & Spalding Among Germany’s Leading Law Firms
November 22, 2022
Ulf Grundmann and Elisabeth Kohoutek represent Novartis before the Court of Justice of the EU, which ruled in favor of the company in a pharma reboxing dispute
Counseling a world-wide leading manufacturer of medicinal products in all aspects of parallel imports in the EU
Counseling a world-wide market leading manufacturer of medical devices in regulatory and advertising law
Counseling internationally acting pharmaceutical companies in the area of distinction between food and pharmaceutical products
See more
March 27, 2023
With Risk Comes Responsibility: EU Proposes High-Risk AI Regulation Affecting Device Manufacturers
January 19, 2023
EU Medicine Reboxing Ruling Gives Guidance To Pharma Cos.
April 12, 2023
Legal 500 EMEA 2023 Recognizes King & Spalding among the Top Firms in Europe, the Middle East and Africa
February 17, 2023
Legal 500 Deutschland 2023 Recognizes King & Spalding Among Germany’s Leading Law Firms
November 22, 2022
Ulf Grundmann and Elisabeth Kohoutek represent Novartis before the Court of Justice of the EU, which ruled in favor of the company in a pharma reboxing dispute
Counseling a world-wide leading manufacturer of medicinal products in all aspects of parallel imports in the EU
Counseling a world-wide market leading manufacturer of medical devices in regulatory and advertising law
Counseling internationally acting pharmaceutical companies in the area of distinction between food and pharmaceutical products
See more
March 27, 2023
With Risk Comes Responsibility: EU Proposes High-Risk AI Regulation Affecting Device Manufacturers
January 19, 2023
EU Medicine Reboxing Ruling Gives Guidance To Pharma Cos.
April 12, 2023
Legal 500 EMEA 2023 Recognizes King & Spalding among the Top Firms in Europe, the Middle East and Africa
February 17, 2023
Legal 500 Deutschland 2023 Recognizes King & Spalding Among Germany’s Leading Law Firms
November 22, 2022
Ulf Grundmann and Elisabeth Kohoutek represent Novartis before the Court of Justice of the EU, which ruled in favor of the company in a pharma reboxing dispute
State Exam, Ruprecht-Karls-Universität Heidelberg
Frankfurt
Frankfurt, Germany (Admitted 3/8/2012; Reg. # 148821)
Czech
English
German
Spanish